Publications by authors named "Gordon Guo"

Claim this Profile
A
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, Marianna Zahurak, Gary L Rosner, Gordon Guo

Eur Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
Gregory K Bartlett, Christopher F Njeh, Ke C Huang, Colleen DesRosiers, Gordon Guo

Med Dosim· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, Alejandro Berlin, Alison Tree, Gordon Guo

Int J Radiat Oncol Biol Phys· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancer.
Elisha T Fredman, Gordon Guo, Daniel E Spratt

Prostate Cancer Prostatic Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective swallowing outcomes after IMRT for oropharyngeal cancer: Dosimetric correlations in a population-based cohort.
Gordon Z Guo, Keith R Sutherland, Candace Myers, Pascal Lambert, Shaun K Loewen

Oral Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.
Henan Zhao, Xiaotang Yu, Yanfang Ding, Jinyao Zhao, Guang Wang, Gordon Zhuo Guo

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
Xinchen Zhang, Gordon Guo, Guang Wang, Jinyao Zhao, Bo Wang

Mol Med Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer.
Henan Zhao, Sha Liu, Guang Wang, Xian Wu, Yanfang Ding, Gordon Guo

Oncol Rep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
Xiaotang Yu, Xinchen Zhang, Tie Bi, Yanfang Ding, Jinyao Zhao, Gordon Guo

Tumour Biol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous detection of miRNAs, their targets and downstream proteins in transferred FFPE sections: applications in clinical and basic research.
Jin-yao Zhao, Chun-qing Liu, He-nan Zhao, Yan-Fang Ding, Tie Bi, Gordon Guo

Methods· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 activates a glomerular-specific enhancer identified from the human nephrin gene.
Gordon Guo, Debra J Morrison, Jonathan D Licht, Susan E Quaggin

J Am Soc Nephrol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis